Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cao

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
Journal of Personalized Medicine|June 28, 2023
Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and EnrollmentJessica A Cao, Sagar B Patel, Calvin W Wong, et al.
Clinical and Experimental Immunology|February 24, 1998
Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III regionF Cucca, Z B Zhu, A Khanna, et al.
Human Mutation|October 26, 1999
Jagged-1 mutation analysis in Italian Alagille syndrome patientsG Pilia, M Uda, D Macis, et al.
Vision (Basel, Switzerland)|November 24, 2025
Geographic Atrophy Progression in Clinical Practice Before and After Pegcetacoplan TreatmentJessica A Cao, Avery W Zhou, Gail M Teagle, et al.
Scientific Reports|January 29, 2024
Pathogenic/likely pathogenic mutations identified in Vietnamese children diagnosed with autism spectrum disorder using high-resolution SNP genotyping platformDuyen T Bui, Anh N V Ton, Chi T D Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Oncogene|October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivoC Eberlein, J Kendrew, K McDaid, et al.
Nature Genetics|February 15, 2001
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndromeL Crisponi, M Deiana, A Loi, et al.
Acta Ophthalmologica Scandinavica. Supplement|February 11, 1999
Molecular basis of open-angle glaucoma in ItalyA Angius, M Pisano, A Sanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Journal of Personalized Medicine|June 28, 2023
Demographic and Socioeconomic Factors in Prospective Retina-Focused Clinical Trial Screening and EnrollmentJessica A Cao, Sagar B Patel, Calvin W Wong, et al.
Clinical and Experimental Immunology|February 24, 1998
Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III regionF Cucca, Z B Zhu, A Khanna, et al.
Human Mutation|October 26, 1999
Jagged-1 mutation analysis in Italian Alagille syndrome patientsG Pilia, M Uda, D Macis, et al.
Vision (Basel, Switzerland)|November 24, 2025
Geographic Atrophy Progression in Clinical Practice Before and After Pegcetacoplan TreatmentJessica A Cao, Avery W Zhou, Gail M Teagle, et al.
Scientific Reports|January 29, 2024
Pathogenic/likely pathogenic mutations identified in Vietnamese children diagnosed with autism spectrum disorder using high-resolution SNP genotyping platformDuyen T Bui, Anh N V Ton, Chi T D Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Oncogene|October 31, 2012
A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivoC Eberlein, J Kendrew, K McDaid, et al.
Nature Genetics|February 15, 2001
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndromeL Crisponi, M Deiana, A Loi, et al.
Acta Ophthalmologica Scandinavica. Supplement|February 11, 1999
Molecular basis of open-angle glaucoma in ItalyA Angius, M Pisano, A Sanca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2021
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative NeoplasmsRaajit K Rampal, Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, et al.
Pageof 36